DELRAY BEACH, Fla.: DELRAY BEACH, Fla. , Dec. 9, 2024 /PRNewswire/ — The global AI in medical diagnostics market is likely to grow from USD 1.71 billion in 2024 to USD 4.72 billion by 2029, at a CAGR of 22.5% during the forecast period. Factors like: The rising availability of big data drive AI breakthroughs, while cross-industry alliances and collaborations among tech companies, healthcare providers, and the government give resources and experience that can be applied to AI applications. For example, in 2024, Microsoft deepened its collaboration with NVIDIA by merging Azure with NVIDIA’s DGX Cloud and Clara suite to advance clinical research, drug discovery, and medical imaging. Similarly, in 2023, Microsoft collaborated with Paige AI to produce the biggest image-based AI models for cancer diagnosis and treatment. It has also teamed up with Nuance. However, a lack of trained AI professionals and uncertain regulatory standards for medical software, which delay down development and implementation, are among the primary issues projected to limit market growth.